Total Payments
$866.08
2024 Payments
$534.28
Companies
12
Transactions
27
Payment Breakdown by Category
Food & Beverage$866.08 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $866.08 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $118.53 | 5 | $0 (2024) |
| Lundbeck LLC | $112.68 | 4 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $112.23 | 1 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $95.51 | 2 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $85.21 | 3 | $0 (2024) |
| ABBVIE INC. | $80.54 | 4 | $0 (2024) |
| ITI, Inc. | $75.89 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $64.65 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $55.48 | 2 | $0 (2024) |
| Axsome Therapeutics, Inc. | $26.53 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $534.28 | 21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($118.53) |
| 2023 | $109.07 | 2 | ITI, Inc. ($75.89) |
| 2022 | $112.23 | 1 | Teva Pharmaceuticals USA, Inc. ($112.23) |
| 2019 | $49.92 | 1 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($49.92) |
| 2018 | $45.59 | 1 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($45.59) |
| 2017 | $14.99 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($14.99) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.84 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Neuropsychiatry | ||||||
| 09/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: PSYCHIATRY | ||||||
| 08/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: PSYCHIATRY | ||||||
| 05/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.59 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $33.24 | General |
| Category: PSYCHIATRY | ||||||
| 01/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.67 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $33.18 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $75.89 | General |
| Category: PSYCHIATRY | ||||||
| 06/16/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $112.23 | General |
| Category: Central Nervous System | ||||||
| 03/30/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $49.92 | General |
About Dr. Nicolas Sikaczowski, DO
Dr. Nicolas Sikaczowski, DO is a Psychiatry healthcare provider based in Saco, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2017. The National Provider Identifier (NPI) number assigned to this provider is 1083147920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicolas Sikaczowski, DO has received a total of $866.08 in payments from pharmaceutical and medical device companies, with $534.28 received in 2024. These payments were reported across 27 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($866.08).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Child & Adolescent Psychiatry
- Location Saco, ME
- Active Since 04/07/2017
- Last Updated 05/27/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1083147920
Products in Payments
- CAPLYTA (Drug) $194.42
- REXULTI (Drug) $168.16
- AUSTEDO (Drug) $112.23
- INGREZZA (Drug) $85.21
- VRAYLAR (Drug) $80.54
- TRINTELLIX (Drug) $64.65
- Auvelity (Drug) $26.53
- COBENFY (Drug) $23.84
- Betaseron (Drug) $14.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.